Therapeutic implications of protein homeostasis in demyelinating peripheral neuropathies

Expert Rev Neurother. 2012 Sep;12(9):1041-3. doi: 10.1586/ern.12.79.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Charcot-Marie-Tooth Disease / drug therapy
  • Charcot-Marie-Tooth Disease / enzymology
  • Charcot-Marie-Tooth Disease / metabolism
  • Demyelinating Diseases / drug therapy*
  • Demyelinating Diseases / enzymology
  • Demyelinating Diseases / metabolism
  • Enzyme Inhibitors / pharmacology
  • Enzyme Inhibitors / therapeutic use*
  • Homeostasis / drug effects
  • Humans
  • Molecular Targeted Therapy*
  • Myelin Sheath / drug effects*
  • Myelin Sheath / enzymology
  • Myelin Sheath / metabolism
  • Nerve Tissue Proteins / antagonists & inhibitors
  • Nerve Tissue Proteins / metabolism*
  • Neurons / drug effects*
  • Neurons / enzymology
  • Neurons / metabolism
  • Peripheral Nervous System Diseases / drug therapy*
  • Peripheral Nervous System Diseases / enzymology
  • Peripheral Nervous System Diseases / metabolism
  • Signal Transduction / drug effects

Substances

  • Enzyme Inhibitors
  • Nerve Tissue Proteins